Vitamin D and breast cancer risk

Best Pract Res Clin Endocrinol Metab. 2008 Aug;22(4):587-99. doi: 10.1016/j.beem.2008.08.002.

Abstract

In addition to its important role in the maintenance of the skeleton, there is mounting evidence that vitamin D has effects on other body systems, and that adequate supplies of vitamin D are likely to be required for optimal health. Vitamin D is obtained both from dietary sources and from cutaneous synthesis with exposure to sunlight. Some epidemiological studies have indicated that vitamin D deficiency and decreased exposure to solar UVB radiation increase the risk of some cancers, including breast cancer. The active metabolite of vitamin D, 1,25-dihydroxy-vitamin D(3), is synthesized primarily in the kidney, and has been shown in laboratory studies to have potent anti-proliferative effects on breast cancer cells. Normal and neoplastic breast tissues contain the vitamin D receptor, and gene ablation studies have implicated the receptor in normal breast development. Several polymorphisms have been identified in the vitamin D receptor gene, and these have been associated with risk of breast cancer in some studies. Local synthesis of 1,25-dihydroxyvitamin D(3) in breast tissue may contribute to maintenance of normal cell function, which could be impaired in vitamin D deficiency.

Publication types

  • Review

MeSH terms

  • Breast Neoplasms / metabolism*
  • Diet
  • Female
  • Humans
  • Polymorphism, Genetic
  • Receptors, Calcitriol / genetics
  • Receptors, Calcitriol / metabolism*
  • Sunlight
  • Vitamin D / administration & dosage
  • Vitamin D / metabolism*

Substances

  • Receptors, Calcitriol
  • Vitamin D